Статті в журналах з теми "Rasburicase"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Rasburicase".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1186 (January 2008): 32. http://dx.doi.org/10.2165/00128415-200811860-00101.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1140 (February 2007): 19. http://dx.doi.org/10.2165/00128415-200711400-00067.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1367 (September 2011): 32. http://dx.doi.org/10.2165/00128415-201113670-00113.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1371 (October 2011): 33. http://dx.doi.org/10.2165/00128415-201113710-00123.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1209 (July 2008): 26–27. http://dx.doi.org/10.2165/00128415-200812090-00084.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1087 (February 2006): 24. http://dx.doi.org/10.2165/00128415-200610870-00081.
Повний текст джерелаOldfield, Vicki, and Caroline M. Perry. "Rasburicase." Drugs 66, no. 4 (2006): 529–45. http://dx.doi.org/10.2165/00003495-200666040-00008.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1284 (January 2010): 36–37. http://dx.doi.org/10.2165/00128415-201012840-00122.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1307 (June 2010): 39. http://dx.doi.org/10.2165/00128415-201013070-00126.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1024 (October 2004): 13. http://dx.doi.org/10.2165/00128415-200410240-00038.
Повний текст джерелаEaston, Jane, Stuart Noble, and Blair Jarvis. "Rasburicase." Paediatric Drugs 3, no. 6 (2001): 433–37. http://dx.doi.org/10.2165/00128072-200103060-00004.
Повний текст джерелаPui, Ching-Hon. "Rasburicase." Paediatric Drugs 3, no. 6 (2001): 438–39. http://dx.doi.org/10.2165/00128072-200103060-00005.
Повний текст джерелаGoldman, Stan. "Rasburicase." Paediatric Drugs 3, no. 6 (2001): 438–39. http://dx.doi.org/10.2165/00128072-200103060-00006.
Повний текст джерелаCada, Dennis J., Terri Levien, and Danial E. Baker. "Rasburicase." Hospital Pharmacy 38, no. 1 (January 2003): 50–57. http://dx.doi.org/10.1177/001857870303800107.
Повний текст джерела&NA;. "Rasburicase." Reactions Weekly &NA;, no. 1426 (November 2012): 37. http://dx.doi.org/10.2165/00128415-201214260-00132.
Повний текст джерелаYim, Barbara, Anne Navaleza, Augustin Haidau, Shylendra Sreenivasappa, Mohammed A. Kassem, Bety C. Ciobanu, Tareq Braik, et al. "Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults." Blood 116, no. 21 (November 19, 2010): 1779. http://dx.doi.org/10.1182/blood.v116.21.1779.1779.
Повний текст джерелаCortes, Jorge, Joseph O. Moore, Richard T. Maziarz, Meir Wetzler, Michael Craig, Jeffrey Matous, Selina Luger, et al. "Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study." Journal of Clinical Oncology 28, no. 27 (September 20, 2010): 4207–13. http://dx.doi.org/10.1200/jco.2009.26.8896.
Повний текст джерелаEng, Stephen, Chung-Shien Lee, Seungjun Ahn, and Amy Sharma. "A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital." Journal of Oncology Pharmacy Practice 26, no. 2 (May 14, 2019): 338–44. http://dx.doi.org/10.1177/1078155219846949.
Повний текст джерелаKassem, Nancy, Halima El Omri, Mohamed Yassin, and Shereen Elazzazy. "BPI19-016: Evaluation of the Use of a Single Dose Rasburicase in Prophylaxis and Management of Tumor Lysis Syndrome (TLS) Among Cancer Patients in Qatar." Journal of the National Comprehensive Cancer Network 17, no. 3.5 (March 8, 2019): BPI19–016. http://dx.doi.org/10.6004/jnccn.2018.7147.
Повний текст джерелаWang, Alice C., Deborah McCue, Farhad Ravandi, Gautam Borthakur, Deborah A. Thomas, Stefan Faderl, William G. Wierda, and Jorge E. Cortes. "Outcomes Of Repeated Administration Of Rasburicase In Recurrent Cycles For Patients With Leukemia." Blood 122, no. 21 (November 15, 2013): 3888. http://dx.doi.org/10.1182/blood.v122.21.3888.3888.
Повний текст джерелаXu, Hui, Frederick Mills, and Edward E. Max. "Intravenous rasburicase-induced immune tolerance is associated with depletion of specific lymphocytes and up-regulation of regulatory T cells." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 125.17. http://dx.doi.org/10.4049/jimmunol.196.supp.125.17.
Повний текст джерелаMcBride, Ali, Melissa Hagan, Mei Xue, and Robert E. Smith. "Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort." Blood 134, Supplement_1 (November 13, 2019): 3401. http://dx.doi.org/10.1182/blood-2019-125922.
Повний текст джерелаEaddy, M., K. O’Day, K. M. Tangirala, and B. Seal. "The economic implications of rasburicase treatment in adult tumor lysis syndrome patients." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e17503-e17503. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17503.
Повний текст джерелаKobayashi, Shunsuke, Takeo Yasu, and Manabu Akazawa. "Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database." Current Oncology 29, no. 12 (December 14, 2022): 9826–32. http://dx.doi.org/10.3390/curroncol29120772.
Повний текст джерелаGenerali, Joyce, and Dennis J. Cada. "Rasburicase: Gout." Hospital Pharmacy 43, no. 3 (March 2008): 194–98. http://dx.doi.org/10.1310/hpj4303-194.
Повний текст джерелаBoutin, Alyssa, Alison Blackman, David M. O’Sullivan, and Nicholas Forcello. "The value of fixed rasburicase dosing versus weight-based dosing in the treatment and prevention of tumor lysis syndrome." Journal of Oncology Pharmacy Practice 25, no. 3 (January 10, 2018): 577–83. http://dx.doi.org/10.1177/1078155217752075.
Повний текст джерелаAllen, Katherine C., Amanda H. Champlain, Jonathan Cotliar, Steven M. Belknap, Dennis P. West, Jayesh Mehta, and Steven Trifilio. "Anaphylaxis Associated with Administration of Repeated Courses of Rasburicase: A Research On Adverse Drug Events and Reports (RADAR) Project." Blood 120, no. 21 (November 16, 2012): 1351. http://dx.doi.org/10.1182/blood.v120.21.1351.1351.
Повний текст джерелаO'Day, K., M. Eaddy, B. Seal, and K. M. Tangirala. "The economic implications of rasburicase treatment in pediatric tumor lysis syndrome patients." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 10050. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10050.
Повний текст джерелаPatel, Komal K., Timothy J. Brown, Arjun Gupta, Taylor Roberts, Eileen Marley, Hsiao C. Li, and Navid Sadeghi. "Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care." Journal of Oncology Practice 15, no. 2 (February 2019): e178-e186. http://dx.doi.org/10.1200/jop.18.00528.
Повний текст джерелаRadtchenko, Janna, Daniel Lyons, Yvonne Barnes, Scott Milligan, and Edward Drea. "Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome." Blood 134, Supplement_1 (November 13, 2019): 2203. http://dx.doi.org/10.1182/blood-2019-124319.
Повний текст джерелаNauffal, Mary, Robert Redd, Jian Ni, Richard M. Stone, Daniel J. DeAngelo, and Anne M. McDonnell. "Single 6-mg dose of rasburicase: The experience in a large academic medical center." Journal of Oncology Pharmacy Practice 25, no. 6 (August 15, 2018): 1349–56. http://dx.doi.org/10.1177/1078155218791333.
Повний текст джерелаHummel, Margit, Dieter Buchheidt, Silke Ulm, Sebastian Reiter, and Rudiger Hehlmann. "Successful Treatment of Tumor Lysis Syndrome (TLS) with Low Doses of Rasburicase in Patients with Impaired Renal Function (IRF)." Blood 106, no. 11 (November 16, 2005): 3332. http://dx.doi.org/10.1182/blood.v106.11.3332.3332.
Повний текст джерелаMyers, Regina M., Kelly D. Getz, Yimei Li, Yuan-Shung V. Huang, Rebecca Citrin, Caitlin W. Elgarten, Benjamin L. Laskin, Joseph P. Horowitz, Brian T. Fisher, and Richard Aplenc. "Comparative Effectiveness of Rasburicase and Allopurinol in Children with Acute Lymphoblastic Leukemia: An Emulated Pragmatic Trial Using Observational Data." Blood 132, Supplement 1 (November 29, 2018): 830. http://dx.doi.org/10.1182/blood-2018-99-114883.
Повний текст джерелаYim, Barbara T., Rosalyn P. Sims-McCallum, and Pang H. Chong. "Rasburicase for the Treatment and Prevention of Hyperuricemia." Annals of Pharmacotherapy 37, no. 7-8 (July 2003): 1047–54. http://dx.doi.org/10.1345/aph.1c336.
Повний текст джерелаIshizawa, Kenichi. "Clinical trials of rasburicase." Gout and Nucleic Acid Metabolism 30, no. 2 (2006): 203–9. http://dx.doi.org/10.6032/gnam1999.30.2_203.
Повний текст джерелаCairo, Mitchell S., Stephen Thompson, Krishna Tangirala, and Michael T. Eaddy. "Costs and Outcomes Associated with Rasburicase Versus Allopurinol in Patients with Tumor Lysis Syndrome." Blood 120, no. 21 (November 16, 2012): 3175. http://dx.doi.org/10.1182/blood.v120.21.3175.3175.
Повний текст джерелаTrifilio, S., M. Tallman, S. Singhal, L. Gordon, A. Evens, and J. Mehta. "Low-Dose Recombinante Urate Oxidase (Rasburicase) Is Effective in Hyperuricemia." Blood 104, no. 11 (November 16, 2004): 3312. http://dx.doi.org/10.1182/blood.v104.11.3312.3312.
Повний текст джерелаJane, Hutchinson Lauren. "P01 A retrospective observational study of the use of rasburicase within a tertiary paediatric oncology centre." Archives of Disease in Childhood 103, no. 2 (January 19, 2018): e1.4-e1. http://dx.doi.org/10.1136/archdischild-2017-314584.12.
Повний текст джерелаRanjan, Alok, Nisha Khanna, Vivek Ranjan, and Ashwin Kumar. "Follow-Up Study on Management of Tumour Lysis Syndrome with Single Low Fixed Dose (1.5 mg) of Rasburicase - A Tertiary Cancer Centre Experience from India." Journal of Evidence Based Medicine and Healthcare 8, no. 25 (June 21, 2021): 2149–54. http://dx.doi.org/10.18410/jebmh/2021/403.
Повний текст джерелаPonnada, Bharadwaj, Saadvik Raghuram, Sanketh Kotne, and Pavithran Keechilat. "The value of low, fixed, single dose rasburicase in the prevention and treatment of tumor lysis syndrome." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e18558-e18558. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18558.
Повний текст джерела"Rasburicase." Reactions Weekly 1851, no. 1 (April 2021): 322. http://dx.doi.org/10.1007/s40278-021-94412-4.
Повний текст джерела"Rasburicase." Reactions Weekly 1925, no. 1 (September 24, 2022): 440. http://dx.doi.org/10.1007/s40278-022-24217-5.
Повний текст джерела"Rasburicase." Reactions Weekly 1877, no. 1 (October 2021): 345. http://dx.doi.org/10.1007/s40278-021-03915-7.
Повний текст джерела"Rasburicase." Reactions Weekly 1878, no. 1 (October 2021): 460. http://dx.doi.org/10.1007/s40278-021-04430-z.
Повний текст джерела"Rasburicase." Reactions Weekly 1862, no. 1 (July 2021): 428. http://dx.doi.org/10.1007/s40278-021-98546-0.
Повний текст джерела"Rasburicase." Reactions Weekly 1871, no. 1 (September 2021): 362. http://dx.doi.org/10.1007/s40278-021-01881-8.
Повний текст джерела"Rasburicase." Reactions Weekly 1896, no. 1 (March 2022): 405. http://dx.doi.org/10.1007/s40278-022-11193-z.
Повний текст джерела"Rasburicase." Reactions Weekly 1926, no. 1 (October 1, 2022): 407. http://dx.doi.org/10.1007/s40278-022-24685-3.
Повний текст джерела"Rasburicase." Reactions Weekly 1691, no. 1 (March 2018): 235. http://dx.doi.org/10.1007/s40278-018-42490-6.
Повний текст джерела"Rasburicase." Reactions Weekly 1692, no. 1 (March 2018): 308. http://dx.doi.org/10.1007/s40278-018-42835-4.
Повний текст джерела